- Home
- SFHG vs TNGX Comparison
SFHG vs TNGX Comparison
Compare SFHG & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- TNGX
- Stock Information
- Founded
- SFHG 1993
- TNGX 2014
- Country
- SFHG Hong Kong
- TNGX United States
- Employees
- SFHG N/A
- TNGX N/A
- Industry
- SFHG Publishing
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- TNGX Health Care
- Exchange
- SFHG Nasdaq
- TNGX Nasdaq
- Market Cap
- SFHG 323.1M
- TNGX 317.4M
- IPO Year
- SFHG 2024
- TNGX N/A
- Fundamental
- Price
- SFHG $0.85
- TNGX $2.36
- Analyst Decision
- SFHG
- TNGX Strong Buy
- Analyst Count
- SFHG 0
- TNGX 8
- Target Price
- SFHG N/A
- TNGX $13.14
- AVG Volume (30 Days)
- SFHG 1.6M
- TNGX 548.6K
- Earning Date
- SFHG 12-20-2024
- TNGX 03-17-2025
- Dividend Yield
- SFHG N/A
- TNGX N/A
- EPS Growth
- SFHG N/A
- TNGX N/A
- EPS
- SFHG 0.01
- TNGX N/A
- Revenue
- SFHG $19,005,455.00
- TNGX $43,383,000.00
- Revenue This Year
- SFHG N/A
- TNGX $27.73
- Revenue Next Year
- SFHG N/A
- TNGX N/A
- P/E Ratio
- SFHG $98.68
- TNGX N/A
- Revenue Growth
- SFHG 31.66
- TNGX 15.67
- 52 Week Low
- SFHG $0.61
- TNGX $2.35
- 52 Week High
- SFHG $24.00
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- SFHG N/A
- TNGX 33.13
- Support Level
- SFHG N/A
- TNGX $2.35
- Resistance Level
- SFHG N/A
- TNGX $2.51
- Average True Range (ATR)
- SFHG 0.00
- TNGX 0.22
- MACD
- SFHG 0.00
- TNGX -0.04
- Stochastic Oscillator
- SFHG 0.00
- TNGX 0.94
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.